Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-19-002999

← back to feed
Filed
May 20, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · May 17, 2019 140.22M sh
Operating Cash Flow Q3 2019 · Mar 31, 2019 −$335.56K
Operating Cash Flow Q3 2019 · Mar 31, 2018 −$684.53K
Cash And Equivalents Q3 2019 · Mar 31, 2019 $19.02K
Cash And Equivalents Q3 2019 · Jun 30, 2018 $64.58K
Cash And Equivalents Q3 2019 · Mar 31, 2018 $30.06K
Cash And Equivalents Q3 2019 · Jun 30, 2017 $11.35K
Stockholders Equity Q3 2019 · Mar 31, 2019 −$6.66M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$6.29M
Stockholders Equity Q3 2019 · Sep 30, 2018 −$6.07M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$5.58M
Stockholders Equity Q3 2019 · Mar 31, 2018 −$5.19M
Stockholders Equity Q3 2019 · Dec 31, 2017 −$4.75M
Stockholders Equity Q3 2019 · Sep 30, 2017 −$4.52M
Stockholders Equity Q3 2019 · Jun 30, 2017 −$4.25M
Current Liabilities Q3 2019 · Mar 31, 2019 $6.69M
Current Liabilities Q3 2019 · Jun 30, 2018 $3.1M
Total Liabilities Q3 2019 · Mar 31, 2019 $6.69M
Total Liabilities Q3 2019 · Jun 30, 2018 $5.68M
Current Assets Q3 2019 · Mar 31, 2019 $21.56K
Current Assets Q3 2019 · Jun 30, 2018 $91.6K
Total Assets Q3 2019 · Mar 31, 2019 $21.56K
Total Assets Q3 2019 · Jun 30, 2018 $91.6K
Sga Expense Q3 2019 · Mar 31, 2019 $213.26K
Sga Expense Q3 2019 · Mar 31, 2019 $615.97K
Sga Expense Q3 2019 · Mar 31, 2018 $313.72K
Sga Expense Q3 2019 · Mar 31, 2018 $790.18K
Rd Expense Q3 2019 · Mar 31, 2019 $32K
Rd Expense Q3 2019 · Mar 31, 2018 $80.4K
Rd Expense Q3 2019 · Mar 31, 2018 $205.03K
Net Income Q3 2019 · Mar 31, 2019 −$390.21K
Net Income Q3 2019 · Mar 31, 2019 −$1.3M
Net Income Q3 2019 · Dec 31, 2018 −$371.14K
Net Income Q3 2019 · Sep 30, 2018 −$537.3K
Net Income Q3 2019 · Mar 31, 2018 −$654.6K
Net Income Q3 2019 · Mar 31, 2018 −$4.5M
Net Income Q3 2019 · Dec 31, 2017 −$3.41M
Net Income Q3 2019 · Sep 30, 2017 −$431.48K